Congress logo
Back to Conference page

UICC World Cancer Congress 2006

Bridging the Gap: Transforming Knowledge into Action

July 8-12, 2006, Washington, DC, USA



Tuesday, 11 July 2006 - 12:00 PM
167-45

Incidence of Fusion Gene Transcripts E2a-Pbx, Tel-Aml, Mbcr-Abl and Mll-Af4 in South Indian Acute Lymphoblastic Lleukemias

KarunakaranNancy Nirmala, PhD1, Sudhakar natarajan1, Rajalekshmy raghavan kamalalyam2, Ramanan Ganapati3, and Rajkumar Thangarajan1. (1) Dept of Mol Oncology, Cancer Institute (WIA), 38 Sardar patel Road, Guindy, Chennai, 600036, India, (2) Dept of hematoimmunology, Cancer Institute (WIA), 38 Sardar patel Road, Guindy, Chennai, 600036, India, (3) Dept of medical oncology, Cancer Institute (WIA), 38 Sardar patel Road, Guindy, Chennai, 600036, India

Objective: To study the incidence of fusion gene transcripts E2A-PBX, TEL-AML, mBCR-ABL and MLL-AF4 in South Indian Acute lymphoblastic leukemias and their prognostic significance.

Methods:Total RNA was isolated from Bone marrow/ Peripheral blood of 67 B-ALL patients at presentation , reverse transcribed to cDNA , PCR done to detect the fusion gene transcripts and sequenced.

Results: Eleven of 67 B-ALL (16.4%) patients revealed one of the 4 risk stratifying translocations. Of the 4 patients with E2A-PBX translocation , one patient died without achieving remission and 3 continue to be in clinical and hematological remission. In 4 B-ALL patients with TEL-AML translocation , 2 declined treatment, one patient died without achieving remission and other continues to be in clinical and hematological remission. Of the 2 mBCR-ABL positive patients one patient is in clinical and hematological remission while the other relapsed after achieving clinical and hematological remission. A one year old child with MLL-AF4 translocation continues to be in clinical and hematological remission. Sequencing revealed no variants in breakpoints.


See more of Cancer Research, Detection and Treatment
See more of Cancer Research, Detection and Treatment

See more of The UICC World Cancer Congress 2006